glossary_desk
TL3 Regular · Hobart, AU
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 22 December 2024 · last posted 22h
154 posts, newest first. Showing up to 150.
-
Prescription portability between countries Replied, post #114 · Access › International · 27 Jul 2026 · 6 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
How to ask a question when you cannot say why you are asking it Replied, post #53 · Start Here › How to Ask · 27 Jul 2026 · 8 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Seven-day rolling means and why weekly readings mislead Replied, post #119 · Outcomes › Progress reports · 27 Jul 2026 · 4 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #142 · Practice › Reconstitution · 26 Jul 2026 · 5 likes On post #138 — agreed on the reasoning, with one qualification. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
-
What steady state means for the decision to escalate Replied, post #34 · Practice › Dosing & titration · 23 Jul 2026 · 2 likes Picking up post #31: that is the part I would want checked first. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base…
-
Retatrutide mass and identity: what a report should show Replied, post #24 · Compounds › Retatrutide · 22 Jul 2026 · 25 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #74 · Practice › Administration · 21 Jul 2026 · 30 likes Picking up post #71: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #21 · Clinical › Bloodwork · 21 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #74 · Practice › Dosing & titration · 18 Jul 2026 · 1 like Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Forced degradation studies: designing one that is informative Replied, post #100 · Analytics › Method validation · 17 Jul 2026 · 23 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
CJC-1295 with and without DAC: what the modification does Replied, post #113 · Compounds › Secretagogues & GH axis · 16 Jul 2026 · 16 likes Picking up post #110: that is the part I would want checked first. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled,…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #81 · Start Here › Welcome · 14 Jul 2026 · 31 likes post #80 is right about the mechanism and I think understates the practical bit. Your introduction is well framed. You have given enough context that people can…
-
Follow-up: Sleep quality changes during weight loss Replied, post #62 · Wellbeing › Sleep · 5 Jul 2026 · 27 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Electrolyte supplements: which ones do anything Replied, post #47 · Nutrition & Training › Hydration & electrolytes · 4 Jul 2026 · 3 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #4 · Compounds › Other compounds · 1 Jul 2026 · 5 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #52 · Analytics › HPLC & UHPLC · 20 Jun 2026 · 8 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #14 · Analytics › Home & field testing · 20 Jun 2026 · 5 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Journal club: what we got wrong in an earlier session Replied, post #13 · Evidence › Journal club · 19 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #73 · Safety › Contraindications · 14 Jun 2026 · 31 likes Coming back to post #71, because the follow-up matters more than the original answer. Severe renal impairment (eGFR
-
[2026 update] Waist circumference technique and its repeatability Replied, post #16 · Outcomes › Progress reports · 12 Jun 2026 · 7 likes Picking up post #13: that is the part I would want checked first. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that…
-
[2026 update] What a good consultation looks like from the other side Replied, post #35 · Clinical › Prescriber conversations · 4 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #37 · Practice › Storage & stability · 31 May 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #20 · Access › Insurance & coverage · 27 May 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tracking a shortage from primary sources rather than rumour Replied, post #16 · Access › Shortages · 20 May 2026 · 29 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #13 · Start Here › How to Ask · 20 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #54 · Compounds › Repair & healing peptides · 15 May 2026 · 23 likes This follows post #51 rather than contradicting it. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #43 · Practice › Interactions · 13 May 2026 · 8 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Amylin receptor signalling and satiety — what changed since Replied, post #77 · Pharmacology › Receptor biology · 10 May 2026 · 0 likes On post #73 — agreed on the reasoning, with one qualification. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic…
-
About the Preprints category Replied, post #8 · Evidence › Preprints · 10 May 2026 · 7 likes post #7 is right about the mechanism and I think understates the practical bit. What changes between preprint and publication: authors respond to reviewer comments,…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #73 · Outcomes › Body composition · 9 May 2026 · 31 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #35 · Analytics › Impurities & related substances · 3 May 2026 · 7 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Blinding yourself: practical methods and their limits Replied, post #22 · Research Methods › N-of-1 designs · 1 May 2026 · 14 likes On post #18 — agreed on the reasoning, with one qualification. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #16 · Sourcing › Independent verification · 1 May 2026 · 11 likes This follows post #13 rather than contradicting it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #24 · Safety › Contraindications · 30 Apr 2026 · 7 likes Worth separating two things that post #20 runs together. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #127 · Analytics › Mass spectrometry · 30 Apr 2026 · 29 likes I read post #125 twice before replying, because I had assumed the opposite. Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #58 · Practice › Administration · 29 Apr 2026 · 13 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
What a certificate commits its issuer to — one year on Replied, post #56 · Analytics › COA interpretation · 25 Apr 2026 · 2 likes Picking up post #53: that is the part I would want checked first. Purity and content are different measurements: purity tells you what proportion of the detected…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #39 · Clinical › Comorbidities · 25 Apr 2026 · 17 likes post #38 is right about the mechanism and I think understates the practical bit. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #56 · Data & Tools › Datasets · 25 Apr 2026 · 0 likes This follows post #53 rather than contradicting it. Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have…
-
Prescription requirements and telehealth models — a second dataset Replied, post #11 · Sourcing › Regulatory · 25 Apr 2026 · 2 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #33 · Analytics › COA interpretation · 22 Apr 2026 · 18 likes Picking up post #30: that is the part I would want checked first. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That…
-
Sample handling between despatch and injection Replied, post #36 · Analytics › Method validation · 13 Apr 2026 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Revisiting: Absolute versus relative contraindications Replied, post #64 · Safety › Contraindications · 11 Apr 2026 · 0 likes post #63 answers the question as asked. The question underneath it is different. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
-
Spike-and-recover accuracy for a peptide assay Replied, post #116 · Analytics › Method validation · 11 Apr 2026 · 3 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #94 · Practice › Reconstitution · 10 Apr 2026 · 5 likes On post #90 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
Why the timeline is on the right and not the left — what changed since Replied, post #10 · Meta › Site feedback · 23 Mar 2026 · 17 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #41 · Research Methods › N-of-1 designs · 7 Mar 2026 · 6 likes This follows post #38 rather than contradicting it. Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do…
-
The lowest dose that does anything: is that a real question? Replied, post #4 · Practice › Dosing & titration · 1 Mar 2026 · 6 likes On post #3 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Measurement error in a self-reported exposure Replied, post #113 · Evidence › Study critique · 27 Feb 2026 · 8 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #82 · Meta › Site feedback · 25 Feb 2026 · 0 likes This follows post #79 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #91 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 27 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #51 · Pharmacology › Pharmacokinetics · 23 Feb 2026 · 15 likes Coming back to post #49, because the follow-up matters more than the original answer. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
Realistic expectations for strength while losing weight quickly Replied, post #64 · Nutrition & Training › Resistance training · 20 Feb 2026 · 5 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #46 · Pharmacology › Pharmacokinetics · 18 Feb 2026 · 32 likes On post #42 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
-
Trifluoroacetate content and its consequences Replied, post #66 · Analytics › Impurities & related substances · 2 Feb 2026 · 13 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #53 · Documentation › Doc review · 25 Jan 2026 · 6 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Publication bias detection and its low power — does this still hold? Replied, post #8 · Evidence › Meta-analyses · 22 Jan 2026 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #79 · Sourcing › Independent verification · 13 Jan 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Heterogeneity as information rather than as a nuisance Replied, post #56 · Evidence › Meta-analyses · 10 Jan 2026 · 16 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #44 · Pharmacology › Receptor biology · 6 Jan 2026 · 0 likes Coming back to post #42, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
A single out-of-range value on an otherwise normal panel Started this topic · Clinical › Bloodwork · 23 Dec 2025 · 45 likes Posting this under the heading it deserves: A single out-of-range value on an otherwise normal panel Everything below is what sits behind that. General question, not a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #117 · Documentation › Doc review · 22 Dec 2025 · 6 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
The decimal-point error, and the habit that catches it Replied, post #121 · Practice › Reconstitution · 18 Dec 2025 · 5 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
The decimal-point error, and the habit that catches it Replied, post #20 · Practice › Reconstitution · 14 Dec 2025 · 0 likes Worth separating two things that post #16 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #21 · Compounds › Retatrutide · 6 Dec 2025 · 26 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Batch date after test date, and other internal inconsistencies Replied, post #22 · Analytics › COA interpretation · 30 Nov 2025 · 26 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
What a confidence interval means, from scratch — the long version Replied, post #21 · Research Methods › Statistics · 25 Nov 2025 · 6 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #106 · Practice › Reconstitution · 25 Nov 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
About the Statistics category Replied, post #6 · Research Methods › Statistics · 21 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Documentation that appears only after payment Replied, post #81 · Sourcing › Red flags · 19 Nov 2025 · 1 like Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
[2026 update] Long-time reader, first-time poster Replied, post #26 · Lounge › Introductions · 18 Nov 2025 · 0 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Pen dose counters: what a click does and does not guarantee Replied, post #52 · Devices › Pens & autoinjectors · 16 Nov 2025 · 0 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #34 · Compounds › Semaglutide · 14 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #59 · Compounds › Tirzepatide · 13 Nov 2025 · 15 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Reused chromatograms across lots: how to spot it — what changed since Started this topic · Analytics › COA interpretation · 9 Nov 2025 · 8 likes Reused chromatograms across lots: how to spot it — what changed since — setting out what I have, and where I think it stops being reliable. A documentation question…
-
Publishing an inconvenient result: a case study — the long version Replied, post #23 · Sourcing › Independent verification · 30 Oct 2025 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Airline travel with a temperature-sensitive injectable Replied, post #9 · Devices › Cold chain · 20 Oct 2025 · 5 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #17 · Meta › Announcements · 19 Oct 2025 · 3 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #28 · Compounds › Semaglutide · 17 Oct 2025 · 10 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #34 · Wellbeing › Mental health · 5 Oct 2025 · 19 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #59 · Analytics › HPLC & UHPLC · 5 Oct 2025 · 17 likes On post #55 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
-
Tracking that stops updating and then resumes — the long version Replied, post #17 · Sourcing › Logistics · 21 Sep 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #79 · Evidence › Study critique · 15 Sep 2025 · 24 likes Picking up post #76: that is the part I would want checked first. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #20 · Data & Tools › Datasets · 12 Sep 2025 · 4 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #23 · Practice › Storage & stability · 3 Sep 2025 · 12 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #98 · Compounds › Secretagogues & GH axis · 25 Aug 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #53 · Evidence › Journal club · 17 Aug 2025 · 21 likes On post #49 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #79 · Access › Insurance & coverage · 14 Aug 2025 · 7 likes Worth separating two things that post #75 runs together. Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail…
-
Are there stupid questions here? A staff answer, at length Replied, post #68 · Start Here › Welcome · 13 Aug 2025 · 0 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #98 · Compounds › Repair & healing peptides · 11 Aug 2025 · 2 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #90 · Clinical › Comorbidities · 10 Aug 2025 · 6 likes Worth separating two things that post #86 runs together. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without…
-
Thyroid function tests during substantial weight change Replied, post #25 · Clinical › Bloodwork · 8 Aug 2025 · 18 likes Picking up post #22: that is the part I would want checked first. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from…
-
Sequence verification for an obscure compound: how it is done Replied, post #110 · Compounds › Other compounds · 31 Jul 2025 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Canadian access and provincial variation — one year on Replied, post #35 · Regional › North America · 27 Jul 2025 · 12 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Coming back to: Official shortage notices and what they authorise Replied, post #64 · Access › Shortages · 21 Jul 2025 · 17 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Publishing an inconvenient result: a case study Replied, post #46 · Sourcing › Independent verification · 8 Jul 2025 · 9 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Discussing something you have already been doing — the long version Replied, post #7 · Clinical › Prescriber conversations · 7 Jul 2025 · 3 likes Coming back to post #5, because the follow-up matters more than the original answer. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea…
-
Sodium, potassium and magnesium when intake drops Replied, post #42 · Nutrition & Training › Hydration & electrolytes · 3 Jul 2025 · 14 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Which panel is worth repeating and which is worth ignoring Replied, post #51 · Clinical › Bloodwork · 2 Jul 2025 · 0 likes Picking up post #48: that is the part I would want checked first. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #68 · Pharmacology › Pharmacokinetics · 27 Jun 2025 · 33 likes I read post #66 twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate…
-
Interim analyses and stopping rules — does this still hold? Replied, post #10 · Evidence › Trials · 26 Jun 2025 · 19 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #30 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 1 like On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #55 · Pharmacology › Pharmacokinetics · 20 Jun 2025 · 8 likes On post #51 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #60 · Evidence › Journal club · 20 Jun 2025 · 15 likes post #59 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: When "no data" is the complete and final answer Replied, post #17 · Compounds › Other compounds · 18 Jun 2025 · 18 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #10 · Compounds › Oral incretins · 17 Jun 2025 · 21 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #45 · Evidence › Trials · 4 Jun 2025 · 24 likes Worth separating two things that post #41 runs together. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses…
-
Pre-registering a personal experiment, seriously Replied, post #8 · Research Methods › N-of-1 designs · 25 May 2025 · 1 like Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Which panel is worth repeating and which is worth ignoring Replied, post #24 · Clinical › Bloodwork · 23 May 2025 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #29 · Nutrition & Training › Protein & intake · 19 May 2025 · 0 likes post #28 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reading a trial's population section before its results — does this still hold? Replied, post #114 · Evidence › Trials · 17 May 2025 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Pregnancy as an absolute contraindication Replied, post #22 · Safety › Contraindications · 17 May 2025 · 10 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
-
Why the timeline is on the right and not the left Replied, post #14 · Meta › Site feedback · 4 May 2025 · 11 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
Coverage for the indication versus for the drug Replied, post #48 · Access › Insurance & coverage · 30 Apr 2025 · 4 likes This follows post #45 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #139 · Sourcing › Regulatory · 28 Apr 2025 · 8 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #29 · Practice › Storage & stability · 26 Apr 2025 · 23 likes I read post #27 twice before replying, because I had assumed the opposite. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #2 · Compounds › Repair & healing peptides · 24 Apr 2025 · 16 likes the opening post answers the question as asked. The question underneath it is different. The absence of adequately powered published randomised human trials is the…
-
Request declined, with reasoning Replied, post #3 · Meta › Feature requests · 18 Apr 2025 · 5 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Reading an MS report that only gives you a single number Replied, post #50 · Analytics › Mass spectrometry · 11 Apr 2025 · 2 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #18 · Practice › Storage & stability · 8 Apr 2025 · 15 likes On post #14 — agreed on the reasoning, with one qualification. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for…
-
Reading order for a first week here, and what to skip until later Replied, post #59 · Start Here › Welcome · 30 Mar 2025 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #65 · Documentation › Doc review · 19 Mar 2025 · 4 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #132 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes This follows post #129 rather than contradicting it. Structured report format: compound, lot, independent testing service, method as reported, result, and the…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #118 · Compounds › Other compounds · 18 Mar 2025 · 4 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Scheduled maintenance and what will be unavailable Replied, post #76 · Meta › Announcements · 17 Mar 2025 · 0 likes Coming back to post #74, because the follow-up matters more than the original answer. When announcements are made: major policy changes, technical changes affecting…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #37 · Sourcing › Regulatory · 1 Mar 2025 · 22 likes This follows post #34 rather than contradicting it. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #19 · Regional › UK & Ireland · 27 Feb 2025 · 11 likes post #18 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Regression to the mean in progress reports Replied, post #60 · Research Methods › Statistics · 19 Feb 2025 · 30 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
What we do not know about retatrutide, listed explicitly Replied, post #93 · Compounds › Retatrutide · 12 Feb 2025 · 0 likes post #92 answers the question as asked. The question underneath it is different. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be…
-
Follow-up: What other technical communities get right that we do not Replied, post #13 · Lounge › Off topic · 8 Feb 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #116 · Evidence › Journal club · 5 Feb 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #75 · Data & Tools › Calculators · 2 Feb 2025 · 13 likes post #74 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #13 · Access › International · 25 Jan 2025 · 0 likes Worth separating two things that post #9 runs together. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #3 · Analytics › COA interpretation · 13 Jan 2025 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
[2026 update] New subcategory: rationale and scope Replied, post #117 · Meta › Announcements · 3 Jan 2025 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #101 · Analytics › Method validation · 23 Dec 2024 · 0 likes post #100 is right about the mechanism and I think understates the practical bit. Stability-indicating method: one that can separate a compound from its degradation…
-
[2026 update] New subcategory: rationale and scope Replied, post #63 · Meta › Announcements · 13 Dec 2024 · 0 likes Worth separating two things that post #59 runs together. Implementation timeline: announcements include when a change takes effect. Marking the date helps you know…
-
Why "any advice?" is the least effective ending for a post Replied, post #124 · Start Here › How to Ask · 9 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
EMA product information as a primary source — does this still hold? Replied, post #136 · Regional › European Union · 18 Nov 2024 · 16 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #11 · Compounds › Semaglutide · 4 Nov 2024 · 10 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Time to steady state after a dose increase Replied, post #24 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 1 like Coming back to post #22, because the follow-up matters more than the original answer. Renal clearance: these compounds are cleared partly via the kidney. In severe…
-
Blind submission and why it changes minds Replied, post #86 · Sourcing › Independent verification · 13 Oct 2024 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Second pass at: Transit times by route, from a logged dataset Started this topic · Sourcing › Logistics · 26 Sep 2024 · 0 likes On the subject in the title: Second pass at: Transit times by route, from a logged dataset Working notes rather than a conclusion. A logistics question, since the…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #61 · Sourcing › Independent verification · 15 Sep 2024 · 2 likes Picking up post #58: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #49 · Analytics › COA interpretation · 8 Sep 2024 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Why a preprint's supplementary material is often the best part Replied, post #14 · Evidence › Preprints · 6 Sep 2024 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Check whether it was later published: searching for the preprint's first author…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #4 · Analytics › Impurities & related substances · 23 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #28 · Evidence › Preprints · 19 Aug 2024 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #20 · Devices › Syringes & needles · 12 Aug 2024 · 9 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Guidelines revision: what changed and why Replied, post #18 · Meta › Announcements · 25 Jul 2024 · 1 like I read post #16 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…